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and industrial culturing, particularly Streptomyces coeli-
color and more recently E. coli [15]. Modular PK/NRP
biosynthetic enzymes pose difficulties in heterologous
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Department of Chemistry and Biochemistry expression for several reasons. First, they are large en-
zymes, usually ranging in molecular weights betweenUniversity of California, San Diego
9500 Gilman Drive 300 and 800 kDa [1]. Their sheer size presents a major
obstacle to their routine cloning and manipulation. Sec-La Jolla, California 92093
ond, the majority of large megasynthase proteins heter-
ologously expressed in E. coli either form insoluble ag-
gregates or show no activity in soluble form. CurrentSummary
metabolic engineering efforts that examine alternative
heterologous hosts and high-throughput combinatorialEngineering biosynthetic pathways into suitable host
techniques face enormous challenges. Achieving properorganisms has become an attractive venue for the
expression, folding, and posttranslational modificationdesign, evaluation, and production of small molecule
of these biosynthetic proteins is a major obstacle to betherapeutics. Polyketide (PK) and nonribosomal pep-
overcome, and advanced techniques to rapidly verifytide (NRP) synthases have been of particular interest
expression and activity parameters are needed.due to their modular structure, yet routine cloning and
A common theme in the biosynthesis of PK and NRPexpression of these enzymes remains challenging.
molecules lies in the posttranslational modification ofHere we describe a method to covalently label carrier
their synthases by 4-phosphopantetheinyltransferasesproteins from PK and NRP synthases using the enzy-
(PPTases) [16]. Specifically, carrier protein (CP) domainsmatic transfer of a modified coenzyme A analog by a
within each biosynthetic system are modified at a con-4-phosphopantetheinyltransferase. Using this method,
served serine residue with a 4-phosphopantetheinecarrier proteins can be loaded with single fluorescent
moiety from coenzyme A (CoA). This modification, asor affinity reporters, providing novel entry for protein
illustrated by the conversion of the apo-carrier proteinvisualization, Western blot identification, and affinity
(apo-CP) to the phosphopantetheinylated holo-carrierpurification. Application of these methods provides an
protein (holo-CP) in Figure 1, is essential for activatingideal tool to track and quantify metabolically engi-
the biosynthesis of PK and NRP metabolites in allneered pathways. Such techniques are valuable to
known producing organisms. The development of suit-measure protein expression, solubility, activity, and
ablemetabolic engineering platforms must overcome is-native posttranslational modification events in heter-
sues related to abnormal protein folding, low solubility,ologous systems.
and poor turnover in large modular synthases. Routine
assays for 4-phosphopantetheinylation might therefore
Introduction provide an ideal entry to monitor the production of active
synthases. The conventional methods to assay for 4-
The biosynthesis of polyketide (PK) and nonribosomal phosphopantetheinylation rely on radiolabeled CoA and
peptide (NRP) natural products has been of great inter- liquid scintillation [17]. Other techniques involve HPLC
est recently for potential new drug discovery and pro- separation and analysis of purified proteins [18]. The
duction [1–3]. Since elucidation of the modular nature implementation of these methods place major limita-
of their biosynthetic machinery, PK and NRP synthases tions on high-throughput operations, such as combina-
have been aggressively studied for directed engineering torial biosynthesis, in which rapid and reliable assays
and combinatorial biosynthesis [4–6], while novel mem- for active biosynthetic proteins are required [10].
bers of these molecular classes continue to be discov- Sfp, the PPTase responsible for modifying surfactin
ered in nature [7, 8]. Future adaptation of molecules synthase in Bacillus subtilis, demonstrates the most pro-
within these classes depends, in part, upon the success- miscuous activity of all known PPTases and is frequently
ful implementation of metabolic engineering or the used in metabolic engineering [17]. An interesting char-
directed manipulation of metabolite formation in heterol- acteristic of Sfp lies in its ability to accept functionalized
ogous hosts [9, 10]. While several examples of engi- thioesters of CoA, such as acetyl-CoA and malonyl-CoA,
neering PK and NRP synthases exist, routine manipula- two predominant intracellular metabolites. Walsh has
tion and expression of complex synthases poses used this ability to great benefit in the transfer of nonnat-
enormous challenges [11–15]. ural NRP substrates and intermediates onto CP domains
Due to difficulties in culturing and metabolite overpro- [19]. These aminoacyl-S-CoA derivatives have proven
duction in natural producer strains such as actinomy- useful in elucidating the mechanisms of NRP synthases,
cetes, bacilli, and filamentous fungi, metabolic engi- particularly C domain specificity and procession. Since
neering of PK and NRP synthases has focused on the PPTase modification serves as a unifying marker of NRP
heterologous expression of biosynthetic clusters in host and PK natural product biosynthesis as well as fatty
organisms more amenable to laboratory manipulation acid biosynthesis, we reasoned that PPTases could also
transfer derivatives of CoA bearing functionality consid-
erably more complex than thioesters. Such a technique*Correspondence: mburkart@ucsd.edu
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Figure 1. Posttranslational Modification of CP Domains in NRP and
Figure 2. Synthesis of CoA DerivativesPK Synthases
Coenzyme A-reporter analogs (2a-f) are created through a MichaelPPTases transfer a 4-phosphopantetheine residue from coenzyme
addition of the thiol in CoA across the olefin of reporter-linked malei-A (CoA) to a conserved serine residue on each apo-CP domain,
mide (Figure 7) in one step. Excess maleimide reporter may becreating the holo-CP and 3-phosphoadenosyl-5-phosphate (PAP).
extracted with organic solvent or removed with thiol-teminating
scavenger resin.
could lead to in vitro labeling of carrier proteins with a
variety of reporters for the purpose of identification and CoA in the same manner as the fluorescent dyes above,
isolation of PK and NRP biosynthetic machinery. Here except thiol-terminating scavenger resin was used for
we demonstrate the utility of chemo-enzymatic modifi- extraction of the unreacted maleimides. -mannosyl
cation with CP domains from various PK and NRP syn- maleimide is not soluble in organic solvents; therefore,
thases with synthetic CoA analogs and Sfp to visualize, scavenger resin extraction is also used with this re-
isolate, and manipulate the biosynthetic proteins in vitro. porter.
PPTases Can Selectively Transfer FluorescentResults and Discussion
CoA Derivatives to Carrier Proteins
To investigate PPTase transfer of nonthioester CoA de-Synthesis of CoA-Reporter Analogs
Given our assumption that PPTases would accept sub- rivatives, Sfp was used for posttranslational modifica-
tion of known, heterologously expressed CP domainsstrates other than thioesters, we chose to create analogs
of CoA that would require simple preparation and purifi- (Figure 3). As a first experiment, we used VibB, a small
protein from the Vibrio cholera vibriobactin biosyntheticcation. To this end, maleimides were chosen for their
specific reactivity with sulfhydryl groups. Michael attack machinery that consists of a modular NRP synthase
system. VibB contains only one carrier protein domainof the thiol in CoA onto a maleimide-linked reporter
molecule would result in selective and irreversible cova- (as represented by apo-CP in Figure 1) and as such is
a perfect model system due to its small size and facilelent attachment [20]. Unreacted maleimide reporter
could then be removed by organic wash or with the use expression in E. coli. Cell lysate was collected from
induced E. coli BL21 cells producing VibB from a pET24of a thiol-terminating scavenger resin. To investigate the
feasibility of this approach (Figure 2), we synthesized expression vector. An aliquot of this lysate was incu-
bated with 2a and recombinant Sfp and analyzed byseveral CoA derivatives (2) with the use of fluorescent-
labeled and affinity reporter-labeled maleimides (Figure SDS-PAGE. When viewed under UV irradiation, recombi-
nant VibB was visualized as a fluorescent band (Figure7). Commercially available fluorescent maleimide 1a
(BODIPY FL N-(2-aminoethyl)maleimide) was first used 4A). Coomassie staining of the gel confirmed the band
to be fluorescently tagged VibB 3a (32.6 kDa) (Figure 4B).to yield analog 2a. Unreacted 1a was extracted from
the media using ethyl acetate. Thin layer chromatogra- Similarly, we tested the formation of other fluorescent
reporters. Comparable labeling (i.e., conversion of apo-phy was used to demonstrate completion of the reaction
and successful extraction of unreacted maleimide. The CP to 3b or c) was obtained after repetition of this experi-
ment with Oregon green 488 maleimide (Figure 7, 1b)same procedure was followed with Oregon green 488
maleimide 1b and N-(7-dimethylamino-4-methylcouma- and N-(7-dimethylamino-4-methylcoumarin-3-yl)malei-
mide (1c) (data not shown). Further proof was obtainedrin-3-yl)maleimide 1c. Affinity reporters were also syn-
thesized. Biotin maleimides 1d and 1e were coupled to by sequence analysis. A gel identical to Figure 4A was
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Figure 3. Functional Manipulation of PK and NRP Carrier Proteins
PPTase is used to catalyze the labeling of apo-CP at a conserved serine residue to yield 4-phosphopantetheine-S-succinyl derivative 3a-f
and PAP. Fluorescent reporters may be used to visualize carrier protein domains at specific excitation and emission wavelengths with SDS-
PAGE. Affinity reporters may be used with affinity proteins and reporter enzymes to visualize carrier protein domains via Western blot or for
purification by affinity chromatography with resin bound affinity proteins.
electrophoretically transferred to a polyvinylidene fluo- mapped to the correct protein, VibB, when searched
with BLAST against 1.4 million sequences in GenBank.ride membrane, and the fluorescent band correspond-
ing to 3a (VibB lane) was excised from the membrane. All three fluorescent analogs 2a-c could be used to label,
visualize, isolate, and sequence VibB.The resulting piece was subjected to N-terminal amino
acid sequencing by Edman degradation [21]. The first Since Sfp has been shown to 4-phosphopantetheiny-
late both modular and iterative NRP and PK synthases,10 amino acids of the returned sequence, “maipkiasyp,”
we sought to demonstrate carrier protein labeling on
other systems. Since iterative systems like type II PK
carrier proteins comprise a major group of PK synthases
[1], we chose ACPs from three different type II PK pro-
ducer strains: frenolicin (fren) from Streptomyces roseo-
fulvus, oxytetracycline (otc) from S. rimosus, and tetra-
cenomycin (tcm) from S. glaucescens. These proteins
were heterologously expressed in E. coli BL21 cells from
pET22 vectors. Cell lysate from IPTG-induced cultures
was treated with 2a and recombinant Sfp and separated
on SDS-PAGE. Each of these carrier proteins was la-
beled as 3a and identified by comparing the uptake of
fluorescence in Figure 4A versus Coomassie staining in
Figure 4B.
Fluorescent Labeling of Carrier Protein Domains
Can Be Used to Quantify Posttranslational
Modification in Engineered Systems
Figure 4. Functional Manipulation of Carrier Proteins
For metabolically engineered systems, carrier proteins
(A) Fluorescent visualization of carrier proteins from E. coli crude become active only after posttranslational modification.
cell lysate after incubation with 3a and Sfp. VibB (lane 1) is a small
This modification can be conducted either by PPTasesNRP carrier protein domain. FrenACP (lane 2), OtcACP (lane 3), and
endogenous to the heterologous host or by the co-TcmACP (lane 4) are three type II PK carrier protein domains.
(B) Coomassie stain of the same gel. expression of a PPTase, often under low-level gene ex-
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Figure 5. Relative Sfp Activity in Engineered
Systems
The amount of TcmACP posttranslationally
modified within the cell at various time points
post-IPTG induction is reported as relative
fluorescence (φr) as given by fluorescence
intensity (φf)/protein concentration (ng/l).
Parenthetical  or  represent the presence
or absence of (Sfp coexpression/exogenous
Sfp added to cell lysate).
(A) (/) Culture without Sfp co-expression
(pREP4-Sfp) and incubated with exoge-
nous Sfp and 2a after cell lysis.
(B) (/) Culture without Sfp co-expression
(pREP4-Sfp) and incubated with only 2a (no
exogenous Sfp).
(C) (/) Culture with Sfp co-expression
(pREP4-Sfp) and incubated with only 2a (no
exogenous Sfp).
(D) Recombinant protein concentration (car-
rier protein) in C (/) as a function of time
postinduction.
(E) (/) Culture with Sfp co-expression
(pREP4-Sfp) and incubated with exoge-
nous Sfp and 2a.
(F) Recombinant protein concentration (car-
rier protein) in (E) (/) as a function of time
postinduction.
pression [11, 12]. The fluorescent CP domain labeling that results in nearly 50% unmodified Tcm ACP. How-
ever, protein concentration at this time point (time  0)technique provides a robust and useful means to com-
pare the in vivo activity of native and differentially ex- is 5- to 10-fold lower than at maximal production levels.
After induction, 4-phosphopantetheinylation of the CPpressed heterologous PPTases. By fluorescently tag-
ging unmodified CP domains in cell lysate, purifying the follows a time-dependent lag, reaching a maximum at
3 hr postinduction with just 4% unmodified protein. Weprotein, and spectrophotometrically comparing fluores-
cently tagged protein versus total protein, one can quan- conclude that this system is sufficient for production of
modified CP domains under high expression.tify the amount of in vivo posttranslationally modified
protein. In this manner, different promoters may be com- This study offers a simple means to evaluate transcrip-
tional regulation as it applies to posttranslational modifi-pared and optimized. We demonstrated this technique
with a common co-expression system, whereby the CP cation of biosynthetic enzymes. Both promoter level and
gene copy number remain critical issues for metabolicdomain was expressed in a pET vector (with a T7 pro-
moter) and the PPTase was expressed in a pREP4 vector engineering efforts [22], and posttranslational modifica-
tion must be carefully optimized. Selective use of pro-(with a lacI promoter). We chose a small CP domain,
TcmACP in a pET22 vector, both with and without co- moters to control these events will be essential to the
production of active enzyme and downstream products.expressed Sfp in a pREP4 vector.
To determine the relative activity of co-expressed Sfp,
we induced a set of cultures of BL21(DE3) E. coli trans- Carrier Protein Western Blot
While fluorescent techniques could be used to identifyformed with tcm ACP, a subset cotransformed with sfp.
The cells were harvested at several postinduction time proteins by direct visualization with very low expression
(25 g/l), where the Coomassie-stained gel indicatedpoints. The cell lysates were treated with an excess of
2a, and a subset was treated with additional recombi- little to no protein present, we also examined more sen-
sitive reporter systems. It was found that Sfp would alsonant Sfp to compare in vitro activity of co-expressed
PPTase. The Tcm ACP in each sample was purified accept biotinylated derivatives 2d-e, therein allowing
protein identification by Western blotting [23]. To thisby nickel chromatography with EDTA elution. Purified
protein 3a was then analyzed for relative fluorescent end, we prepared 2d and 2e from N-biotinoyl-N-(6-
maleimidohexanoyl)hydrazide (1d) and biotinyl-3-malei-intensity as a function of total protein concentration,
and these results were tabulated to reveal amount of in midopropionamidyl-3,6-dioxaoctanediamine (1e), re-
spectively. Aliquots containing 2d were incubated withvitro labeling in the engineered system (Figure 5). Here
carrier proteins unmodified in vivo were fluorescently Sfp and cell lysate from apo-VibB-producing E. coli.
Following SDS-PAGE, the gel was electrotransferred totagged in the cell lysate. This experiment indicates that
Sfp insufficiently tags Tcm ACP when expressed at a low nitrocellulose and incubated sequentially with streptavi-
din-linked alkaline phosphatase and 5-bromo-4-chloro-level prior to induction by IPTG. Here, the lac promoter
allows basal levels of expression (“leaky” expression) 3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT)
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Figure 6. Western Blot
(A) Following SDS-PAGE separation of cell lysate (Figure 4A), analy-
sis using reporter 2e (lane 1) or 2d (lane 2). Lane 3 represents CoA
spiked with 10% 2d used in the PPTase labeling reaction.
(B) Coomassie stain of the same gel.
(C) Western blot visualization of DEBS1, DEBS2, and DEBS3 from
crude cell lysate of S. erythreaea after incubation with Sfp and 3e.
Lane 2 is a 2-fold dilution of sample volume from lane 1.
(D) Coomassie stain of the gel in (C). Here, DEBS proteins are not
visible by Coomassie.
(Figure 6A). Here, carrier protein could be detected at
a limit of 100 pg/lane (or 5 ng/ml). As expected, we did
encounter some conditions that yielded a high back-
ground level due to the labeling of native E. coli proteins.
To counter this effect, we found that diluting derivative
2d with CoA lowered the background and increased the
selection of carrier proteins within E. coli cell lysate
(Figure 6A, lane 3). This experiment qualitatively illus-
trates that Sfp accepts both CoA and its analogs 2 with
comparable efficiency. Additionally, we examined the
effects of tether length. A second botinylated derivative
Figure 7. Maleimide Reporters Used in Coenzyme A Analog Prepa-
2e demonstrated roughly double the efficiency for strep- ration
tavidin association by Western blot, suggesting a steric
requirement for streptavidin binding.
This technique also imparts modest utility in identi- preparation. Clearly, natural PPTases in producer organ-
isms effectively modify the majority of available CP do-fying CP domains from the lysate of native cultures.
While natural product producer strains express PPTases mains. We are currently investigating methods to revert
or inhibit 4-phosphopantetheinylation to alleviate thissufficient for posttranslational modification of their na-
tive carrier proteins, a small percentage of unmodified issue.
sites remain after cell lysis. These unmodified CP do-
mains may still be used for in vitro reporter tagging Affinity Chromatography
We reasoned that the above labeling methods could bewith Sfp for protein visualization. Western blotting of PK
synthase enzymes has been demonstrated using the transferred to affinity purification techniques in order to
isolate synthases with carrier protein domains [25]. Cell6-deoxyerythronolide B synthase (DEBS) system from
Saccharopolyspora erythraea and polyclonal antibodies lysate with apo-VibB was incubated with Sfp and 2d,
and the mixture was run over a small column loadedraised against the recombinant proteins [24]. We chose
to use the DEBS system for our first native CP-tagging with streptavidin-linked agarose resin. Following wash-
ing, the resin was boiled to release biotin bound protein.experiments. A type I modular PK synthase, DEBS repre-
sents a class of synthases in which cloning, expression, A sample was subjected to SDS-PAGE and a Western
blot against streptavidin-phosphatase conjugate. Bothand purification difficulties are particularly acute. We
found that the DEBS proteins from native culture could the Coomassie-stained gel and the Western blot indi-
cated that biotin-tagged VibB 3f was successfully puri-be identified by our CP-labeling Western blot techniques
following incubation of cell lysate with Sfp and 2e (Figure fied with biotin affinity chromatography.
Due to denaturation involved in the recovery from6B). Here, DEBS1, DEBS2, and DEBS3, with molecular
weights of 365.1, 374.5, and 331.5 kDa, respectively, streptavidin/biotin affinity purification, we also exam-
ined the nondenaturing conditions given by the affinityran as one band and were readily visualized in amounts
below the detection limit of Coomassie visualization. A between carbohydrate-tagged proteins (i.e., -manno-
sylated proteins) and lectin-linked agarose resins (i.e.,faint band seen at 150 kDa was a native biotin-labeled
protein. Unfortunately, tagging efficiency remained only concanavalin A). Here, we coupled maleimide 1f to CoA
to yield -mannoside 2f [26]. Incubating 2f with cell ly-modest, and Western blot visualization proved to be
acutely sensitive to the media for culture growth, the sate of E. coli producing recombinant VibB and exoge-
nous Sfp, we produced 3f (VibB) with -mannosyltiming of cell harvesting, and the conditions of cell lysate
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(Novagen, Madison, WI), were pelleted, resuspended, and lysed bygroups. An aliquot of this mixture was bound to conca-
sonication in 30 ml 0.1 M Tris-Cl (pH 8.0) with 1% glycerol in thenavalin A-linked agarose and washed on a small column.
presence of 500 l of a 10 mM protease inhibitor cocktail containingBound protein was eluted off the agarose with a gradient
bestatin, pepstatin A, E-64, and phosphoramidon (Sigma-Aldrich)
of glucose, and the purified protein was identified with and sonicated by pulsing for 5 min on ice. Alternatively, a lysozyme
SDS-PAGE to yield a single band that was identified digestion was used in which the pellet was resuspended in lysis
by Western blotting against concanavalin A-peroxidase buffer A (20 mM Na2HPO4 [pH 7.8], 500 mM NaCl, 1 mg/ml lysozyme)
and cooled on ice, and lysis buffer B (5% Triton X 100, 20 U/mlconjugate (data not shown). This protocol therefore pro-
DNase I, 20 U/ml RNase) to 20% volume was then added. A 40 lduced pure, nondenatured -mannosylated VibB 3f. In
aliquot of a 100 M solution of 2a (Figure 2) was added 200 l ofthe purified form, VibB is not catalytically active, as the
cell lysate containing overexpressed protein and 1 l of a 34 mg/ml
4-phosphopantetheinyl thiol remains covalently bound solution of purified Sfp, and the reaction was incubated at room
to the reporter. However, other domains associated with temperature for 30 min in darkness. When required (Figure 5), recom-
the CP domain (for example, condensation, adenylation, binant His-tagged carrier proteins were purified by nickel chroma-
tography using Ni-NTA His-Bind Resin (Novagen) according to man-and thioesterase domains in NRP synthases) retain ac-
ufacturer prodecure and dialyzed against 0.1 M Tris-HCl (pH 8.4)tivity, and functional studies on these domains remains
with 1% glycerol. Proteins were precipitated with 10% trichloroace-viable. We conclude that this technique can be used
tic acid, pelleted, and washed, and the pellet was resuspended inwith a variety of affinity methods and will further allow
1:1 mixture of 1.0 M Tris-HCl (pH 6.8) and 2 SDS-PAGE sample
functional characterization of other active domains buffer (100 mM Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 0.02%
within a purified synthase. We are currently investigating bromophenol blue). The samples were in boiled for 5 min and sepa-
methods by which to reconstitute activity from labeled rated using SDS-PAGE electrophoresis on a 12% Tris-Glycine.
Tagged proteins were visualized by trans-illumination (  365 nm)carrier protein domains.
and the resulting images captured with CCD camera using a 475 nm
cutoff filter. Protein concentration was determined using the Brad-Significance
ford method with bovine serum albumin (Sigma-Aldrich) as a
standard.
Here we have shown a robust system for specifically
labeling carrier protein domains within PK and NRP
Expression Time Course Studiessynthases. This technique provides novel access to
Cultures of BL21(DE3) with TcmACP and (/)Sfp were grown inthe fluorescent labeling, Western blotting, and affinity
100 ml of LB medium supplemented with the corresponding antibiot-purification of carrier proteins. We suggest that these
ics. Gene expression was induced at OD590  0.6 with 1 mM ITPG.tools provide a powerful means to screen, quantify,
At the indicated time points, 15 ml aliquots were removed from the
and isolate these enzymes. Given the size and com- culture, cooled, and pelleted. Pellets were lysed and spun, and 250
plexity of multidomain biosynthetic systems, tech- l of lysate was added to 100 l of a 100 M solution of 2a (Figure
niques are needed to quantify expression, solubility, 3). The reaction initiated with (/)1 l (30 mg/ml) purified Sfp or
1 l water. Reactions were incubated in the dark at room tempera-folding, activity, and posttranslational modification of
ture for 30 min, and the proteins were purified by nickel chromatog-these proteins in heterologous expression systems.
raphy with EDTA elution. 150 l of the eluates were analyzed forThese techniques can serve as powerful diagnostic
fluorescent intensity (excitation,   492 nm; emission,   535 nm).tools in metabolic engineering and combinatorial bio-
synthesis programs and may also be applicable in the
search for natural product biosynthetic machinery in Western Blotting
novel producer strains. Following SDS-PAGE separation of cell lysate using reporter 2e or
2f, the gel was electrophoretically transferred to nitrocellulose. Blots
Experimental Procedures were incubated with 5% milk in TBST for 30 min at room temperature
with shaking. The blots were then assayed with 10 ml of 5% milk
Coenzyme A Analog Preparation in TBST solution containing either 10 l of 25 mg/ml concanavalin
Six different analogs were prepared using the maleimides in Figure A-peroxidase (Sigma-Aldrich) or 10 l of 25 mg/ml streptavidin-
7. Fluorescent maleimides 1a-c (Molecular Probes, Seattle, WA), 1d alkaline phosphatase conjugate (Pierce Chemical Co., Rockford, IL).
(Sigma-Aldrich, Milwaukee, WI), and 1e (Quanta Biodesign, Powell, Following incubation at room temperature for 1 hr, the blot was
OH) were obtained. -mannoside 1f was prepared according to washed 3 for 10 min with 20 ml of TBST at room temperature and
Ahmed et al. [25]. An aliquot of maleimide 1 (4.8 l of 25 mg/ml incubated in 2 ml of either peroxidase substrate solution (Sigma-
solution of 1a in DMSO, 13.5 l of a 10 mg/ml solution of 1b in Aldrich) containing 0.6 mg/ml 3,3-diaminobenzidine tetrahydrochlo-
DMSO, 8.7 l of a 10 mg/ml solution of 1c in DMSO, 5.2 l of a 25 ride in 50 mM Tris (pH 7.6) and 5 l 30% hydrogen peroxide or
mg/ml solution of 1d in DMSO, 6.0 l of a 25 mg/ml solution of 1e
alkaline-phosphatase substrate solution containing 0.15 mg/ml
in DMSO, and 4.0 l of a 25 mg/ml solution of 1f in DMSO) was
BCIP, 0.30 mg/ml NBT, 100 mM Tris (pH 9.0), 5 mM MgCl2 (pH 9.5)added to coenzyme A disodium salt (300 g, 0.37 mol) in 1.9 ml
(Sigma-Aldrich).MES acetate and 100 mM Mg(OAc)2 at pH 6.0 containing 300 l For DEBS Western, Saccharopolyspora erythraea was grown ac-DMSO. The resulting solution was vortexed briefly, cooled for 30
cording to Caffrey et al. [24], in minimal medium (0.2 M sucrose, 20min at 0	C, and warmed at room temperature for 10 min. CoA-
mM succinic acid, 20 mM K2SO4 [pH 6.6], 5 mM Mg2SO4, 100 mMmaleimide formation was followed by thin layer chromatography
KNO3, 2 ml/l trace element solution). 100 ml 1 liter of culture was(butanol/HOAc/water, 5:2:4). Extraction of the completed reaction
inoculated with a 100 ml 3-day growth and allowed to grow for 4with ethyl acetate (3  10 ml) was effective in removing excess 1a
days. Cells were centrifuged and resuspended in 50 ml resuspensionand 1c; the other maleimides were removed using scavenger resins
buffer: 50 mM Tris-Cl (pH 7.5), 50% (v/v) glycerol, 2 mM DTT, 0.4N-linked 3-thiopropanoic acid PL-PEGA (Polymer Laboratories, Am-
mM PMSF, 100 g/ml DNase, 20 g/ml RNase, and 1 l/ml bacterialherst, MA) or PS-thiophenol (Argonaut, Forester City, CA). This pro-
protease inhibitor coctail (Sigma-Aldrich). The suspension was soni-cedure provided stock solutions containing 100–125 M 2a-f as
cated 10 30 s and ultracentrifuged 2 hr at 40,000  g, and thedetermined by fluorescence analysis.
supernatant was labeled with Sfp and 3e. The reaction product was
separated by a 3%–8% Tris-acetate SDS-PAGE. The resulting gelCarrier Protein Labeling Procedure
was blotted onto nitrocellulose and developed as above with strep-One liter of E. coli BL21 (DE3) cells induced to express recombinant
VibB, FrenACP, OtcACP, and TcmACP, each in pET22b vectors tavidin-alkaline phosphatase conjugate and BCIP/NBT.
Proteomic Tools for Antibiotic Engineering
201
Affinity Chromatography Heterologous expression of an engineered biosynthetic path-
way: functional dissection of type II polyketide synthase compo-Following cell lysis, 200 l supernatant was combined with 40 l of
either 2d-e or 2f and 1 l of 11 mg/ml purified Sfp and allowed to nents in Streptomyces species. J. Bacteriol. 177, 1202–1207.
14. Kealey, J.T., Liu, L., Santi, D.V., Betlach, M.C., and Barr, P.J.react for 30 min at room temperature in the dark. For 2d-e, 20 l
of agarose-immobilized streptavidin (4 mg/ml streptavidin on 4% (1998). Production of a polyketide natural product in nonpolyke-
tide-producing prokaryotic and eukaryotic hosts. Proc. Natl.beaded agarose, Sigma-Aldrich) was added, and the samples were
incubated at 4	C for 1 hr with constant vigorous shaking. After Acad. Sci. USA 95, 505–509.
15. Pfeifer, B.A., and Khosla, C. (2001). Biosynthesis of polyketidescentrifugation, the supernatant was decanted and the samples were
washed 3 with a solution containing 100 mM Tris-HCl (pH 8.4) and in heterologous hosts. Microbiol. Mol. Biol. Rev. 65, 106–118.
16. Lambalot, R.H., Gehring, A.M., Flugel, R.S., Zuber, P., LaCelle,1% SDS in water. After washing, the samples were boiled in 50 l
1 SDS sample buffer for 10 min and centrifuged, and the superna- M., Marahiel, M.A., Reid, R., Khosla, C., and Walsh, C.T. (1996).
A new enzyme superfamily—the phosphopantetheinyl trans-tant run on a 12% Tris-Glycine SDS-PAGE gel and analyzed by
Western blot. For 2f, 20 l of agarose-immobilized concanavalin A ferases. Chem. Biol. 3, 923–936.
17. Quadri, L.E., Weinreb, P.H., Lei, M., Nakano, M.M., Zuber, P.,(4 mg/ml Jack bean concanavalin on 4% beaded agarose, Sigma-
Aldrich) was added with binding buffer (1.3 mM CaCl2, 1.0 mM MgCl2, and Walsh, C.T. (1998). Characterization of Sfp, a Bacillus subti-
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